logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Huyabio International, LLC

USPTO Granted Patents = 12


Trademarks = 1

Forward Citations = 4

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Mireille Gillings (8 out of 12 patents)

silverMedal Suzanne J Romano (7 out of 8 patents)

bronzeMedal Gary Elliott (7 out of 30 patents)

4.  Robert Goodenow (6 out of 9 patents)

5.  Hayley Reece (2 out of 9 patents)

6.  Joseph Edward Gordon Benson (2 out of 3 patents)

7.  Sarah Collins (2 out of 3 patents)

8.  Curtis Tyree (2 out of 3 patents)

9.  Reid P Bissonnette (2 out of 5 patents)

10.  Alain Rolland (2 out of 7 patents)

11.  Farbod Shojaei (2 out of 5 patents)

12.  Jay Mason (2 out of 2 patents)

13.  Waldemar Radziszewski (2 out of 2 patents)

14.  Jill M Ricono (2 out of 2 patents)

15.  Qidong You (1 out of 12 patents)


12 patents:

1. 12678422 - Sulcardine salts (2026-07-14),
2. 12465587 - Sulcardine administration for treatment of acute atrial fibrillation (2025-11-11),
3. 12390469 - SHP2 inhibitor monotherapy and uses thereof (2025-08-19),
4. 12357611 - Sulcardine administration for treatment of acute atrial fibrillation (2025-07-15),
5. 12122833 - Combination therapies of HDAC inhibitors and PD-1 inhibitors (2024-10-22),
6. 12097203 - Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors (2024-09-24),
7. 12054478 - Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction (2024-08-06),
8. 11883380 - Sulcardine administration for treatment of acute atrial fibrillation (2024-01-30),
9. 11813245 - Sulcardine administration for treatment of acute atrial fibrillation (2023-11-14),
10. 11535670 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors (2022-12-27),
11. 11426382 - Sulcardine salts (2022-08-30),
12. 11364223 - Sulcardine administration for treatment of acute atrial fibrillation (2022-06-21),
Company Overview
Huyabio International, LLC is a biotechnology company based in San Diego, California, specializing in the development of innovative therapeutics. The organization focuses on advancing drug candidates across various therapeutic areas, including oncology and autoimmune diseases. Huyabio leverages cutting-edge research and technology to enhance treatment options and improve patient outcomes. With a commitment to scientific excellence, the company collaborates with global partners to bring novel solutions to the healthcare market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#448 in San Diego, CA

#6,066 in California

#25,578 in US

#48,209 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Huyabio International, LLC

Forward Citations = 4

19 inventors:

goldMedal Mireille Gillings (8 out of 12 patents)

silverMedal Suzanne J Romano (7 out of 8 patents)

bronzeMedal Gary Elliott (7 out of 30 patents)

4.  Robert Goodenow (6 out of 9 patents)

5.  Hayley Reece (2 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Huyabio International, LLC. Retrieved from https://idiyas.com/company/huyabio-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…